Sec Form 4 Filing - BUNKA CHRISTOPHER @ Lexaria Bioscience Corp. - 2025-05-15

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person BUNKA CHRISTOPHER 2. Issuer Name and Ticker or Trading Symbol Lexaria Bioscience Corp. [ LEXX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) SUITE 100, 740 MCCURDY ROAD 3. Date of Earliest Transaction (MM/DD/YY) 05/15/2025 (Street) KELOWNA, A1V1X 2P7 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price common shares 373,543 ( 1 ) D common shares 254,412 I Private Holding Company

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Options $ 3 04/26/2021 04/26/2026 Common Shares 26,000 26,000 D Stock Options $ 3 06/08/2021 06/08/2026 Common Shares 23,334 49,334 D Stock Options $ 3 09/01/2021 09/01/2026 Common Shares 15,000 64,334 D Stock Options $ 2.91 08/29/2022 08/29/2027 Common Shares 30,000 94,334 D Stock Options $ 1.15 10/26/2023 10/26/2028 Common Shares 30,000 124,334 D Stock Options $ 2.36 04/26/2024 04/26/2029 Common Shares 49,500 173,834 D Stock Options $ 1.04 05/15/2025 A 11,000 05/15/2025 05/15/2030 Common Shares 11,000 $ 0 184,834 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other BUNKA CHRISTOPHER SUITE 100 740 MCCURDY ROAD KELOWNA, A1V1X 2P7 X Signatures /Christopher Bunka/ 05/16/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.